CYPREMVY Trademark

Trademark Overview


On Tuesday, September 2, 2025, a trademark application was filed for CYPREMVY with the United States Patent and Trademark Office. The USPTO has given the CYPREMVY trademark a serial number of 99369032. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 25, 2025. This trademark is owned by ModernaTx, Inc.. The CYPREMVY trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
cypremvy

General Information


Serial Number99369032
Word MarkCYPREMVY
Filing DateTuesday, September 2, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, November 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 25, 2025

Trademark Statements


Goods and ServicesVaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 2, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, September 2, 2025NEW APPLICATION ENTERED
Tuesday, September 2, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 2, 2025APPLICATION FILING RECEIPT MAILED
Thursday, October 23, 2025ASSIGNED TO EXAMINER
Thursday, October 23, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, November 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords


cypremvy human vaccines